Protective effects of the sickle cell gene against malaria morbidity and mortality

Lancet

Volumn 359, Issue 9314, 2002, Pages 1311-1312

  Aidoo, Michael ^a   Terlouw, Dianne J ^b,c   Kolczak, Margarette S ^a   McElroy, Peter D ^a   Ter Kuile, Feiko O ^a,b,c   Kariuki, Simon ^b   Nahlen, Bernard L ^a,b   Lal, Altaf A ^a   Udhayakumar, Venkatachalam ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; HEMOGLOBIN S;

ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDEMIC DISEASE; FEVER; GENE FREQUENCY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MORBIDITY; MORTALITY; PARASITEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0037070775     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08273-9     Document Type: Article

References (5)

1. Polymorphism and natural selection in human populations
2. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children
3. All-cause mortality among young children in western Kenya. VI: The Asembo Bay Cohort Project
4. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III: The Asembo Bay Cohort Project
5. Common west African HLA antigens are associated with protection from severe malaria